Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmyocardial laser revascularization.

M Nathan1, S Aranki

  • 1Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

Current Opinion in Cardiology
|October 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2026 American Association for Thoracic Surgery (AATS) expert consensus statement: Antithrombotic management of neonates/infants undergoing cardiac interventions.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Influences on nurses' engagement in antimicrobial stewardship behaviours: a multi-country survey using the Theoretical Domains Framework.

The Journal of hospital infection·2022
Same author

Do we really need guidelines for high resolution anoscopy during the COVID-19 pandemic? - Response.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020
Same author

Can we do more with HIV testing?

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.

AJNR. American journal of neuroradiology·2014
Same author

The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.

AJNR. American journal of neuroradiology·2014
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
See all related articles

Transmyocardial laser revascularization (TMR) uses lasers to create channels in the heart for severe coronary artery disease (CAD). While FDA-approved as sole therapy, its mechanism of action requires further investigation.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Procedures
  • Laser Technology in Medicine

Background:

  • Transmyocardial laser revascularization (TMR) evolved from early attempts in the 1980s using low-powered lasers as an adjunct to coronary artery bypass graft surgery (CABG).
  • High-powered lasers, introduced in 1990, enable TMR to create transmyocardial channels with reduced thermal damage, making it suitable for patients with severe, diffuse coronary artery disease (CAD) and refractory angina.

Purpose of the Study:

  • To review the background of transmyocardial laser revascularization (TMR).
  • To analyze recently published randomized studies on TMR.
  • To discuss the current understanding and remaining questions regarding TMR's mechanism of action.

Main Methods:

  • Review of historical data on laser use in cardiac surgery.

Related Experiment Videos

  • Analysis of clinical studies evaluating TMR as a sole operative therapy for severe CAD.
  • Examination of results from four controlled randomized studies comparing TMR outcomes.
  • Assessment of data supporting FDA approval for TMR laser systems.

    • Main Results:

    • TMR is FDA-approved as a sole therapy for specific patient populations with severe CAD and angina.
    • Four controlled randomized studies have been published, with data from two forming the basis for FDA approval.
    • Despite clinical application and approval, the precise mechanism of action for TMR remains unclear.

    Conclusions:

    • Transmyocardial laser revascularization (TMR) is an established therapy for select patients with severe coronary artery disease (CAD).
    • Further research is needed to elucidate the underlying mechanism of action of TMR.
    • Ongoing studies are investigating the efficacy of combined TMR and CABG procedures.